1. Academic Validation
  2. Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives

Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives

  • J Med Chem. 2010 Nov 25;53(22):8089-103. doi: 10.1021/jm1009605.
Antonio Garofalo 1 Laurence Goossens Brigitte Baldeyrou Amélie Lemoine Séverine Ravez Perrine Six Marie-Hélène David-Cordonnier Jean-Paul Bonte Patrick Depreux Amélie Lansiaux Jean-François Goossens
Affiliations

Affiliation

  • 1 Univ Lille Nord de France, F-59000 Lille, France.
Abstract

New N-alkylanilinoquinazoline derivatives 5, 12, 20, and 22 have been prepared from 4-chloro-6,7-dimethoxyquinazoline 3, 4-chloro-6,7-methylenedioxyquinazoline 19, and commercially available anilines. Differents classes of compounds substituted by an aryloxygroup (6a-c, 16a,b, and 17a,b), (aminophenyl)ureas (12a,b and 13a-f), anilines (4a-m, 20a,b), N-alkyl(aniline) (5a-m, 21a,b, 22a,d), and N-aminoalkyl(aniline) (22e-g) have been synthesized. These molecules were evaluated for their cytotoxic activities and as potential DNA intercalating agents. We studied the strength and mode of binding to DNA of these molecules by DNA melting temperature measurements, fluorescence emission, and circular dichroism. The results of various spectral and gel electrophoresis techniques obtained with the different compounds, in particular compounds 5g and 22f, revealed significant DNA interaction. These experiments confirm that the N-aminoalkyl(anilino)-6,7-dimethoxyquinazoline nucleus is an efficient pharmacophore to trigger binding to DNA, via an intercalative binding process.

Figures